Healthcare provider profile · identity verified

Raquel Canete, MD

Internal Medicine · FARMINGTON, CT · NPI 1942594197

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	352	111
Amlodipine Besylate	Amlodipine Besylate	181	60
Losartan Potassium	Losartan Potassium	180	55
Rosuvastatin Calcium	Rosuvastatin Calcium	157	66
Hydrochlorothiazide	Hydrochlorothiazide	150	46
Levothyroxine Sodium	Levothyroxine Sodium	142	41
Lisinopril	Lisinopril	121	33
Metformin Hcl Er	Metformin Hcl	114	36
Alprazolam	Alprazolam	110	31
Metoprolol Succinate	Metoprolol Succinate	110	36
Simvastatin	Simvastatin	94	27
Escitalopram Oxalate	Escitalopram Oxalate	83	18
Lorazepam	Lorazepam	83	19
Gabapentin	Gabapentin	82	34
Albuterol Sulfate Hfa	Albuterol Sulfate	74	27
Oxycodone Hcl	Oxycodone Hcl	66	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	66	19
Allopurinol	Allopurinol	64	20
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	63	21
Montelukast Sodium	Montelukast Sodium	61	22
Diclofenac Sodium	Diclofenac Sodium	60	29
Omeprazole	Omeprazole	59	17
Zolpidem Tartrate	Zolpidem Tartrate	59	19
Duloxetine Hcl	Duloxetine Hcl	56	17
Sertraline Hcl	Sertraline Hcl	56	17
Telmisartan	Telmisartan	54	14
Valsartan	Valsartan	52	19
Meloxicam	Meloxicam	49	26
Trazodone Hcl	Trazodone Hcl	46	19
Atenolol	Atenolol	42	suppressed
Ozempic	Semaglutide	42	11
Clonazepam	Clonazepam	41	12
Metformin Hcl	Metformin Hcl	41	14
Pravastatin Sodium	Pravastatin Sodium	41	14
Pantoprazole Sodium	Pantoprazole Sodium	37	14
Fluticasone Propionate	Fluticasone Propionate	36	19
Tramadol Hcl	Tramadol Hcl	36	15
Nystatin	Nystatin	35	13
Furosemide	Furosemide	34	14
Carvedilol	Carvedilol	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	11
Valacyclovir	Valacyclovir Hcl	31	14
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Eliquis	Apixaban	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Lidocaine	Lidocaine	24	12
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Ezetimibe	Ezetimibe	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Azithromycin	Azithromycin	16	12
Mirtazapine	Mirtazapine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Glimepiride	Glimepiride	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error